• Probenecid: Unraveling Its Role in Tumor Immunometabolism...

  2025-10-20

  Explore how Probenecid, a potent MRP inhibitor, uniquely modulates tumor immunometabolism and neuroprotection. This article delves into emerging mechanisms, including CD8+ T cell metabolic flexibility and calpain-cathepsin pathway inhibition, offering fresh insights beyond traditional multidrug resistance research.

• Aprotinin (BPTI): Mechanistic Innovation and Strategic Ho...

  2025-10-19

  Explore how Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) transcends conventional serine protease inhibition, driving breakthroughs in fibrinolysis, inflammation, and surgical blood management. This thought-leadership article provides mechanistic insight, experimental context, and strategic guidance for translational researchers, leveraging evidence from recent high-throughput protocols and highlighting next-generation applications for cardiovascular and disease-focused research.

• Probenecid at the Nexus of Multidrug Resistance and Neuro...

  2025-10-18

  This thought-leadership article provides an in-depth exploration of Probenecid’s multidimensional role as an inhibitor of organic anion transporters, multidrug resistance-associated proteins (MRPs), and pannexin-1 channels. With direct reference to recent immunometabolic discoveries and translational oncology-neuroscience intersections, it offers mechanistic clarity, validated workflows, and a forward-looking roadmap for researchers seeking to overcome multidrug resistance and neuroinflammation. The discussion is enriched by critical findings from high-impact literature and internal knowledge assets, delivering actionable insights that go beyond conventional product resources.

3 records 1/1 page